Spiked Conc. (ng∙g−1) |
| 17 β-estradiol | Estrone | 17 α-ethinylestradiol | Estriol |
6.0 | RC (ng∙g−1)a MR (%) Std Dev CV (%) AD (%)b | 6.40 106.7 0.36 5.57 6.73 | 6.11 101.8 0.34 5.57 1.87 | 6.11 101.8 0.19 3.05 1.80 | 6.02 100.3 0.24 4.01 0.4 |
60.0 | RC (ng∙g−1)a MR (%) Std Dev CV (%) AD (%) | 62.16 103.6 2.68 4.31 3.60 | 62.28 103.8 2.53 4.06 3.80 | 64.00 106.7 3.47 5.42 6.67 | 60.88 101.5 1.65 2.72 1.47 |
180.0 | RC (ng∙g−1)a MR (%) Std Dev CV (%) AD (%) | 182.80 101.6 7.35 4.02 1.56 | 176.48 98.0 8.12 4.60 1.96 | 195.16 108.4 13.22 6.77 8.42 | 179.04 99.5 8.14 4.55 0.53 |